Levonorgestrel 1.5 Unicorn 1,5 mg Tablet
PDF Leaflet Revision Date: 24 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Emergency contraception within 72 hours of unprotected intercourse.
Dosage (summary)
One tablet as soon as possible, no later than 72 hours after intercourse.
Special Populations
- Severe hepatic impairment
- History of depression
Pregnancy & Breastfeeding
Not for use in pregnancy; minimal transfer to breast milk; avoid nursing for 8 hours post-dose.
Key Drug Interactions
- CYP3A4 inducers
- Efavirenz
- Phenytoin
- Carbamazepine
Contraindications
- Hypersensitivity to levonorgestrel
- Severe hepatic impairment
- Pregnancy
- Uncontrolled depression
Common side effects
- Nausea
- Headache
- Dizziness
- Fatigue
Counselling Points
- Take as soon as possible after unprotected intercourse
- Consider regular contraception after use
- Does not protect against STIs
Serious warnings
- Not a regular contraceptive method
- Risk of ectopic pregnancy
- Mood changes and depression
Important Disclaimer
The Levonorgestrel 1.5 Unicorn 1,5 mg Tablet professional information leaflet below is the property of Unicorn Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
